Steven G. Wolfe

411 total citations
7 papers, 321 citations indexed

About

Steven G. Wolfe is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Steven G. Wolfe has authored 7 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Steven G. Wolfe's work include Cancer therapeutics and mechanisms (2 papers), Estrogen and related hormone effects (2 papers) and Endometriosis Research and Treatment (2 papers). Steven G. Wolfe is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Estrogen and related hormone effects (2 papers) and Endometriosis Research and Treatment (2 papers). Steven G. Wolfe collaborates with scholars based in United States and United Kingdom. Steven G. Wolfe's co-authors include Brad R. Henke, Howard R. Sauls, Timothy M. Willson, Philip G. Baer, Paul S. Charifson, Dennis B. Lubahn, Linda B. Moore, Kenneth W. Batchelor, Guoxiang Xiong and Marcelo B. Antunes and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Endocrinology.

In The Last Decade

Steven G. Wolfe

7 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven G. Wolfe United States	6	192	94	71	60	39	7	321
Y Yamaguchi Japan	6	142 0.7×	196 2.1×	136 1.9×	53 0.9×	15 0.4×	15	384
Kenneth W. Batchelor United States	9	138 0.7×	159 1.7×	53 0.7×	111 1.9×	48 1.2×	12	442
B L Wagner United States	6	262 1.4×	153 1.6×	64 0.9×	12 0.2×	18 0.5×	7	592
Lun Tan China	12	60 0.3×	205 2.2×	40 0.6×	68 1.1×	54 1.4×	26	426
Audrey Castet France	8	206 1.1×	281 3.0×	79 1.1×	27 0.5×	6 0.2×	10	394
Laurent Bermont France	11	83 0.4×	207 2.2×	78 1.1×	11 0.2×	68 1.7×	23	398
Tianfang Ma China	12	29 0.2×	199 2.1×	52 0.7×	86 1.4×	21 0.5×	24	357
Alessandra de Cupis Italy	10	84 0.4×	201 2.1×	133 1.9×	73 1.2×	12 0.3×	15	363
Marc Dufour Switzerland	9	84 0.4×	235 2.5×	66 0.9×	91 1.5×	12 0.3×	10	375
Fahmida Rasha United States	10	52 0.3×	119 1.3×	85 1.2×	56 0.9×	6 0.2×	15	334

Countries citing papers authored by Steven G. Wolfe

Since Specialization

Citations

This map shows the geographic impact of Steven G. Wolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven G. Wolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven G. Wolfe more than expected).

Fields of papers citing papers by Steven G. Wolfe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven G. Wolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven G. Wolfe. The network helps show where Steven G. Wolfe may publish in the future.

Co-authorship network of co-authors of Steven G. Wolfe

This figure shows the co-authorship network connecting the top 25 collaborators of Steven G. Wolfe. A scholar is included among the top collaborators of Steven G. Wolfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven G. Wolfe. Steven G. Wolfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Daniel, Davey B., Jerome H. Goldschmidt, Paul Fields, et al.. (2021). Effects of trilaciclib prior to chemotherapy ± atezolizumab on T-cell activation in patients with newly diagnosed extensive-stage small cell lung cancer.. Journal of Clinical Oncology. 39(15_suppl). e20582–e20582. 2 indexed citations

Kuchava, Vladimer, Igor Bondarenko, О. І. Іващук, et al.. (2019). Trilaciclib (T) decreases myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy plus atezolizumab. Annals of Oncology. 30. v713–v713. 6 indexed citations

Kurrasch, Regina, Judith C. Brown, Myron Chu, et al.. (2013). Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics. The Journal of Rheumatology. 40(7). 1089–1096. 34 indexed citations

Bhargave, Geeta, Bradford A. Woodworth, Guoxiang Xiong, et al.. (2008). Transient Receptor Potential Vanilloid Type 4 Channel Expression in Chronic Rhinosinusitis. American Journal of Rhinology. 22(1). 7–12. 46 indexed citations

Camilleri, Michael, D A Drossman, Lynne Hamm, et al.. (1998). Alosetron, a 5HT3-receptor antagonist, is effective in the treatment of female irritable bowel syndrome patients. Gastroenterology. 114. A812–A812. 18 indexed citations

Willson, Timothy M., John D. Norris, B L Wagner, et al.. (1997). Dissection of the Molecular Mechanism of Action of GW5638, a Novel Estrogen Receptor Ligand, Provides Insights into the Role of Estrogen Receptor in Bone*. Endocrinology. 138(9). 3901–3911. 100 indexed citations

Willson, Timothy M., Brad R. Henke, Paul S. Charifson, et al.. (1994). 3-[4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic Acid: A Non-Steroidal Estrogen with Functional Selectivity for Bone over Uterus in Rats. Journal of Medicinal Chemistry. 37(11). 1550–1552. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact